HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Clinical trials for HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to shrink head and neck tumors before main treatment
Disease control Not yet recruitingThis study tests a combination of the immunotherapy drug toripalimab with two chemotherapy drugs (cisplatin and docetaxel) as an initial treatment for people with advanced head and neck cancer that has a specific marker (CPS-positive). The goal is to see if this approach is safe …
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 20, 2026 12:08 UTC
-
New study aims to save smiles after head and neck cancer treatment
Disease control Not yet recruitingThis study tests whether extra dental support for head and neck cancer survivors can prevent or reduce late side effects like tooth loss, jaw stiffness, and cavities. About 300 adults who finished cancer treatment will receive an oral care program every three months for three yea…
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Uppsala University • Aim: Disease control
Last updated May 18, 2026 11:59 UTC